Literature DB >> 8479287

Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain.

C Cerruti1, D M Walther, M J Kuhar, G R Uhl.   

Abstract

Dopamine transporter mRNA expression in individual neurons from the substantia nigra pars compacta. 'All' area, arcuate nucleus of the hypothalamus, retina, and olfactory bulb was assessed by in situ hybridization. High levels of expression were noted over individual neurons in midbrain nuclei; much lower expression was found in cells of the inner nuclear layer of the retina, glomerular cell layer of the olfactory bulb, and medial aspect of the arcuate nucleus of the hypothalamus. The low levels of expression in the latter nuclei are consistent with the paucity of effects of cocaine in visual and olfactory systems, failure to detect photoaffinity-labelled transporter protein in hypothalamus or olfactory bulb, and observations that little or no damage is found in dopaminergic neurons outside the basal midbrain in idiopathic Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479287     DOI: 10.1016/0169-328x(93)90187-t

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  21 in total

1.  Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult In vitro.

Authors:  N Miao; M Wang; J A Ott; J S D'Alessandro; T M Woolf; D A Bumcrot; N K Mahanthappa; K Pang
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.

Authors:  M J Nirenberg; J Chan; A Pohorille; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

3.  The primate thalamus is a key target for brain dopamine.

Authors:  Miguel Angel Sánchez-González; Miguel Angel García-Cabezas; Beatriz Rico; Carmen Cavada
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

4.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

5.  Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice.

Authors:  D J Gerber; T D Sotnikova; R R Gainetdinov; S Y Huang; M G Caron; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

6.  Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study.

Authors:  N Drandarevski; A Marburger; D Walther; T Reum; G Uh; R Morgenstern
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.

Authors:  Judith P Golden; Joseph A Demaro; Amanda Knoten; Masato Hoshi; Elizabeth Pehek; Eugene M Johnson; Robert W Gereau; Sanjay Jain
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

Review 8.  Toxin models of mitochondrial dysfunction in Parkinson's disease.

Authors:  Terina N Martinez; J Timothy Greenamyre
Journal:  Antioxid Redox Signal       Date:  2011-07-12       Impact factor: 8.401

9.  Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.

Authors:  T J Counihan; J B Penney
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

10.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.